Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase

Area of Science:

• Vascular Biology
• Molecular Medicine
• Biochemistry

Background:

• Abdominal aortic aneurysm (AAA) is a prevalent condition in the elderly, characterized by aortic expansion and rupture.
• Current nonsurgical treatment options for AAA are limited due to an incomplete understanding of its molecular pathogenesis.
• Identifying key molecular players is crucial for developing effective therapeutic strategies.

Purpose of the Study:

• To identify proximal signaling molecules involved in the molecular pathogenesis of abdominal aortic aneurysm.
• To investigate the role of JNK signaling in AAA development and progression.
• To evaluate the therapeutic potential of selective JNK inhibition in AAA.

Main Methods:

• Analysis of phosphorylated JNK levels in human AAA tissues.
• Investigating JNK-mediated gene expression patterns in different cell types.
• Utilizing mouse models to assess the effects of selective JNK inhibition in vivo.

Main Results:

• Human AAA tissues exhibit elevated levels of phosphorylated JNK.
• JNK signaling orchestrates gene expression to promote extracellular matrix degradation and suppress matrix synthesis.
• Selective JNK inhibition prevented AAA formation and induced regression of established AAA in mouse models.

Conclusions:

• JNK is identified as a key proximal signaling molecule in AAA pathogenesis.
• JNK promotes aberrant extracellular matrix metabolism in AAA.
• Targeting JNK signaling represents a promising therapeutic strategy for abdominal aortic aneurysm.